AI system
- System
-
Smartwatch irregular-rhythm notification (brand and model not stated)
- Model
-
Not assessed
- Release
-
Not assessed
- Application developer
-
Not stated (the report does not name the device's maker)
- Role
-
Not assessed
- Configuration
-
Not assessed
- Inputs and outputs
-
Not assessed
- Autonomy
-
Not assessed
- Workflow
-
A wearer with symptomatic AF whose smartwatch issued repeated irregular-rhythm notifications. The wearer acting on the notifications by attending an emergency department. Clinicians confirming the rhythm on a 12-lead ECG and treating it.
- Human oversight
-
Not assessed
- Relation to AI
-
The watch's own notification, repeated several times, is what the report says prompted the visit. Clinicians confirmed AF on a 12-lead ECG and chose cardioversion. The brand is unknown, so the algorithm behind the notification cannot be identified. The authors describe smartwatch rhythm detection generically as deep-neural-network analysis of pulse waves.
- AI contribution
-
The watch's own notification, repeated several times, is what the report says prompted the visit. Clinicians confirmed AF on a 12-lead ECG and chose cardioversion. The brand is unknown, so the algorithm behind the notification cannot be identified. The authors describe smartwatch rhythm detection generically as deep-neural-network analysis of pulse waves.
Benefits
- Outcome identifiers
-
Not assessed
- Benefit
-
atrial fibrillation with rapid ventricular response at 123 bpm
- Category
-
Improved Physical Health
- Status
-
Not assessed
- Beneficiary groups
-
People.
- Beneficiaries
-
Not assessed
- Reach
-
Not assessed
- Distribution and access
-
Not assessed
- Duration
-
Not assessed
- Expected?
-
Yes
- Costs and harms
-
Not assessed
Measurement
- Studies
-
Not assessed
- Study design
-
Not assessed
- Measurement
-
Not assessed
- Setting and sample
-
Not assessed
- Measures
-
atrial fibrillation with rapid ventricular response at 123 bpm
- Comparison
-
Not assessed
- Results
-
atrial fibrillation with rapid ventricular response at 123 bpm
- Additional value from AI
-
Not assessed
- Limitations
-
Not assessed
- Denominators
-
Not assessed
- Materials for replication
-
Not assessed
Money
- Kind of value
-
Not assessed
- Amount
-
Not assessed
- Currency and prices
-
Not assessed
- Period and unit
-
Not assessed
- Realization
-
Not assessed
- Recipients and payers
-
Not assessed
- Gross or net
-
Not assessed
- Included costs
-
Not assessed
- Comparison
-
Not assessed
- Method
-
Not assessed
- Return and payback
-
Not assessed
People and places
- Participants
-
Developer: Not stated (the report does not name the device's maker).
- Jurisdictions
-
Benefit: Abington,
United States (authors' hospital; the report does not name the emergency department). - Ownership and control
-
Not assessed
- Dependencies
-
Not assessed
- Cross-border connections
-
Not assessed
- Geopolitical implications
-
Not assessed
Follow-up
- Conditions for replication
-
The watch's notification corresponds to a true arrhythmia (the authors cite a positive predictive value of 84% for irregular-pulse notifications in the Apple Heart Study). The wearer treats the notification as a reason to seek care.
- Replication attempts
-
1 follow-up entries. Benefit recurred: 1.
- Later findings
-
The report ends with monthly cardiology follow-up recommended; nothing later was found.
- Availability
-
Not assessed
- Institutional decision
-
Not assessed
- Grounds
-
Not assessed
- Action and result
-
Not assessed
- Success criterion
-
Not assessed
Evidence
- Source numbers
-
AIBD-0285-source-0001–0002
- Citations
-
Numbered references below.
- Language
-
Not assessed
- Source relationships
-
Independent
- Original evidence
-
Not assessed
- Access and versions
-
Not assessed
- Supported findings
-
Not assessed
- Evidence links
-
Not assessed
- Evidence strength
-
Not assessed
- Missing evidence
-
Not assessed
Grades
- Assessed benefits
-
People.
- Depth
-
People: 2.
- Reasons
-
People: A 25-year-old received an ECG-confirmed AF diagnosis, cardioversion to sinus rhythm and four weeks of anticoagulation. A material benefit to one person, not described as life-saving.
- Observed or intended
-
Not assessed
- Rubric
-
Not assessed
- Assessor and date
-
Not assessed
- Alternative assessments
-
Not assessed
- Fill
-
Independently studied
Entry details
- Kind
-
Not assessed
- Related entries
-
Not assessed
- Field
-
Healthcare (cardiology). Consumer wearables.
- Purpose
-
Smartwatch irregular-rhythm notifications are built to prompt the wearer to seek medical review. This benefit was that purpose.
- Dates
-
Date basis unassessed: 2023 (precision unassessed). Updated: 21 October 2026.
- Stage
-
Not assessed
- Version
-
SHA-256: 2c98991014f1…
References
- Other identifiers
-
Not assessed
- Category mappings
-
Not assessed
- Brief
-
Not assessed
- Revisions
-
3 revisions. Latest: 21 October 2026.
Sources
-
Case report Independent author
Bedi A, Al Masri MK, Al Hennawi H, Qadir S, Ottman P (2023). The Integration of Artificial Intelligence Into Patient Care: A Case of Atrial Fibrillation Caught by a Smartwatch. Cureus 15(3):e35941. doi:10.7759/cureus.35941 (PMC10082624).
The patient sought medical attention after his smartwatch notified him several times of an irregular heart rhythm consistent with atrial fibrillation (AF)
Upon the cardiologist's recommendation, the patient underwent transesophageal echocardiography (TEE)-guided electrical cardioversion the next day, and normal sinus rhythm was successfully restored.